Evidence map›Paper›PMID 34638169›Full record

ArticleGenomics & informatics2021

Improving classification of low-resource COVID-19 literature by using Named Entity Recognition.

Oscar Lithgow-Serrano, Joseph Cornelius, Vani Kanjirangat, Carlos-Francisco Méndez-Cruz, Fabio Rinaldi

Abstract read
In one paragraph

Article in Genomics & informatics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Oscar Lithgow-SerranoDalle Molle Institute for Artificial Intelligence Research, IDSIA USI-SUPSI, Polo universitario Lugano-Campus Est, Via la Santa 1, CH-6962 Lugano, Switzerland.
Joseph CorneliusDalle Molle Institute for Artificial Intelligence Research, IDSIA USI-SUPSI, Polo universitario Lugano-Campus Est, Via la Santa 1, CH-6962 Lugano, Switzerland.
Vani KanjirangatDalle Molle Institute for Artificial Intelligence Research, IDSIA USI-SUPSI, Polo universitario Lugano-Campus Est, Via la Santa 1, CH-6962 Lugano, Switzerland.
Carlos-Francisco Méndez-CruzCentro de Ciencias Genómicas, Universidad Nacional Autónoma de México, Avenida Universidad s/n Col. Chamilpa, 62210 Cuernavaca, Mor., Mexico.
Fabio RinaldiDalle Molle Institute for Artificial Intelligence Research, IDSIA USI-SUPSI, Polo universitario Lugano-Campus Est, Via la Santa 1, CH-6962 Lugano, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Automatic document classification for highly interrelated classes is a demanding task that becomes more challenging when there is little labeled data for training. Such is the case of the coronavirus disease 2019 (COVID-19) Clinical repository-a repository of classified and translated academic articles related to COVID-19 and relevant to the clinical practice-where a 3-way classification scheme is being applied to COVID-19 literature. During the 7th Biomedical Linked Annotation Hackathon (BLAH7) hackathon, we performed experiments to explore the use of named-entity-recognition (NER) to improve the classification. We processed the literature with OntoGene's Biomedical Entity Recogniser (OGER) and used the resulting identified Named Entities (NE) and their links to major biological databases as extra input features for the classifier. We compared the results with a baseline model without the OGER extracted features. In these proof-of-concept experiments, we observed a clear gain on COVID-19 literature classification. In particular, NE's origin was useful to classify document types and NE's type for clinical specialties. Due to the limitations of the small dataset, we can only conclude that our results suggests that NER would benefit this classification task. In order to accurately estimate this benefit, further experiments with a larger dataset would be needed.

Indexed as

classificationCOVID-19Named Entity RecognitionNLP

Identifiers

PMID34638169
PMCPMC8510872

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.